For this indication, competent medicine agencies globally authorize below treatments:
3,000,000 - 9,000,000 [iU]
From 3,000,000 To 9,000,000 [iU] once every 2 day(s)
The usual dose is 5 million IU (3 to 9 million IU) administered subcutaneously three times a week (every other day). Patients with advanced disease may require a daily dose of 5 million IU. The treatment is to be temporarily discontinued during and after surgery. Therapy may continue for as long as the patient responds to interferon alfa-2b treatment.